Midday Movers: Pump Up the Volume
NEW YORK (TheStreet) -- Several small-cap stocks were moving on above-average volume during Friday's session.
Synovus Financial (SNV) dropped by 74 cents, or 20.8%, to $2.83 after the company late Thursday posted a loss of $437.7 million, or $1.27 a share, swelling from a year ago and nearly doubling the loss analysts expected. Volume topped 43.8 million shares, compared to the three-month average daily volume of 13.3 million, according to Yahoo! Finance.
Elan (ELN) tumbled by $1, or 15.5%, to $5.44 after reports that European regulators are investigating reports of 23 cases of Tysabri patients with a potentially fatal brain infection. Tysabri is a multiple sclerosis drug developed by Elan and partner Biogen Idec (BIIB). Volume topped 32.6 million shares, compared to the three-month average daily volume of 2.7 million, according to Yahoo! Finance.
Grubb & Ellis (GBE) rose by 24 cents, or 16%, to $1.74 after the company said it would sell 900,000 shares of convertible preferred stock for $90 million in gross proceeds in order to boost capital levels. Some investors posting on Internet message boards said the announcement effectively means massive dilution to save the company. Volume topped 2.2 million shares, compared to the three-month average daily volume of 867,000, according to Yahoo! Finance.
Columbia Laboratories (CBRX) slumped by 25 cents, or nearly 20%, to $1.02 after the company said it will sell 10.9 million shares of common stock and warrants to purchase 5,450,000 shares of its common stock in a registered direct offering. The transaction will raise approximately $11.7 million, the company said. Each unit will be sold at a negotiated price of $1.08 per unit. Volume topped 2 million shares, compared to the 50-day average daily volume of 182,000, according to the Nasdaq.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV